Strain identifier
BacDive ID: 8416
Type strain: 
Species: Mycobacterium abscessus
Strain Designation: L948, 14 042 0023
Strain history: CIP <- 1995, V. Vincent, Inst. Pasteur, Paris, France: strain 14 042 0023 <- ATCC <- P. Hauduroy: strain L948 <- M. Moore
NCBI tax ID(s): 36809 (species)
version 8.1 (current version)
General
@ref: 11592
BacDive-ID: 8416
DSM-Number: 44196
keywords: genome sequence, 16S sequence, Bacteria, mesophilic, human pathogen
description: Mycobacterium abscessus L948 is a mesophilic human pathogen of the family Mycobacteriaceae.
NCBI tax id
- NCBI tax id: 36809
- Matching level: species
strain history
| @ref | history |
|---|---|
| 11592 | <- A. F. Yassin, Univ. Bonn, Inst. Med. Mikrobiol.; ATCC 19977 <- ATCC; ATCC 19977 <- P. Hauduroy; Hauduroy L948 <- M. Moore; |
| 67770 | CIP 104536 <-- V. Vincent 14 042 0023 <-- ATCC 19977 <-- P. Hauduroy L948 <-- M. Moore. |
| 115980 | CIP <- 1995, V. Vincent, Inst. Pasteur, Paris, France: strain 14 042 0023 <- ATCC <- P. Hauduroy: strain L948 <- M. Moore |
doi: 10.13145/bacdive8416.20230509.8.1
Name and taxonomic classification
LPSN
- @ref: 20215
- description: domain/bacteria
- keyword: phylum/actinomycetota
- domain: Bacteria
- phylum: Actinomycetota
- class: Actinomycetes
- order: Mycobacteriales
- family: Mycobacteriaceae
- genus: Mycobacterium
- species: Mycobacterium abscessus
- full scientific name: Mycobacterium abscessus (Moore and Frerichs 1953) Kusunoki and Ezaki 1992
synonyms
@ref synonym 20215 Mycobacterium chelonae subsp. abscessus 20215 Mycobacterium chelonei subsp. abscessus 20215 Mycobacterium abscessus 20215 Mycobacteroides abscessus
@ref: 11592
domain: Bacteria
phylum: Actinobacteria
class: Actinobacteria
order: Actinomycetales
family: Mycobacteriaceae
genus: Mycobacterium
species: Mycobacterium abscessus subsp. abscessus
full scientific name: Mycobacterium abscessus subsp. abscessus (Moore and Frerichs 1953) Leao et al. 2011 emend. Tortoli et al. 2016
strain designation: L948, 14 042 0023
type strain: yes
Morphology
cell morphology
| @ref | motility | confidence | gram stain | cell shape |
|---|---|---|---|---|
| 69480 | no | 95.946 | ||
| 69480 | 100 | positive | ||
| 115980 | no | positive | rod-shaped |
colony morphology
| @ref | colony color | incubation period | medium used |
|---|---|---|---|
| 19848 | Beige | 10-14 days | 5006 |
| 19848 | Beige | 10-14 days | BUG |
| 19848 | Beige | 10-14 days | MB7H9 |
multimedia
| @ref | multimedia content | intellectual property rights | caption |
|---|---|---|---|
| 11592 | https://www.dsmz.de/microorganisms/photos/DSM_44196-1.jpg | © Leibniz-Institut DSMZ | |
| 11592 | https://www.dsmz.de/microorganisms/photos/DSM_44196.jpg | © Leibniz-Institut DSMZ | Medium 645 28°C |
Culture and growth conditions
culture medium
| @ref | name | growth | link | composition |
|---|---|---|---|---|
| 11592 | MIDDLEBROOK MEDIUM (DSMZ Medium 645) | yes | https://mediadive.dsmz.de/medium/645 | Name: MIDDLEBROOK MEDIUM (DSMZ Medium 645) Composition: Bacto Middlebrook 7H10 agar 20.9945 g/l Glycerol Distilled water |
| 19848 | BUG | yes | ||
| 19848 | 5006 | yes | Medium: 5006 Name: Composition (g/l) Sucrose 3,0 Dextrin 15,0 Meat extract 1,0 Yeast extract 2,0 Tryptone soy broth (Oxoid) 5,0 NaCl 0,5 K2HPO4 0,5 MgSO4 x 7 H2O 0,5 FeSO4 x 7 H2O 0,01 Agar 20,0 Preparation: Sterilisation: 20 minutes at 121°C pH before sterilisation: 7,3 Usage: Maintenance Organisms: All Actinomycetes | |
| 19848 | MB7H9 | yes | Name: Middlebrook 7H9 (MB7H9) Broth Base Composition: Middelbrook 7H9 Broth Base 4.7 g/l Glycerol 2.0 g/l Casaminoacids 11.0 g/l Yeast extract 5.5 g/l Tween80 (20%) 2.5 g/l OADC-Enrichment 100 ml Agar 15.0 g/l Preparation: Dissolve in Milli-Q-H2O. Before Use add 10% OADC stock solution Sterilisation: 20 minutes at 121°C pH before sterilisation: Usage: Maintenance and revitalization Organisms: Mycobacteria OADC stock solution old broth-name: OADC-Stock Composition: Bovine Serum Albumin, fraction V 5 % 1% Oleic Acid in 0.2N NaOH 5ml Glucose 2 % NaCl 0.85 % Comments: Melt 1% Oleic Acid in 65°C water bath. Dissolve all ingredients in 700ml of ddH2O. Adjust volume to 1L. Filter sterilize and store at 4°C. -To make 1% Oleic Acid in 0.2N NaOH: Dissolve 5g oleic acid (ampule) in 500ml 0.2N NaOH (300ml ddH2O + 20ml NaOH + adjust volume to 500ml). Heat solution to 55°C for oleic acid to melt. Store at -20°C in 50ml aliquots. There is no need to sterilize this. Sterilisation: 20 minutes Temperature:121°C PH before: PH after: Biological details Culture type: suitable for: Mycobacteria | |
| 37180 | MEDIUM 55 - for Mycobacterium | yes |
culture temp
| @ref | growth | type | temperature | range |
|---|---|---|---|---|
| 19848 | positive | optimum | 37 | mesophilic |
| 37180 | positive | growth | 37 | mesophilic |
| 67770 | positive | growth | 37 | mesophilic |
| 11592 | positive | growth | 28 | mesophilic |
Physiology and metabolism
spore formation
| @ref | spore formation | confidence |
|---|---|---|
| 69481 | no | 100 |
| 69480 | no | 99.871 |
metabolite utilization
| @ref | Chebi-ID | metabolite | utilization activity | kind of utilization tested |
|---|---|---|---|---|
| 68379 | 17632 | nitrate | - | reduction |
| 68379 | 4853 | esculin | + | hydrolysis |
| 68379 | 16199 | urea | + | hydrolysis |
| 68379 | 5291 | gelatin | - | hydrolysis |
| 68379 | 17634 | D-glucose | - | fermentation |
| 68379 | 16988 | D-ribose | - | fermentation |
| 68379 | 65327 | D-xylose | - | fermentation |
| 68379 | 16899 | D-mannitol | - | fermentation |
| 68379 | 17306 | maltose | - | fermentation |
| 68379 | 17716 | lactose | - | fermentation |
| 68379 | 17992 | sucrose | - | fermentation |
| 68379 | 28087 | glycogen | - | fermentation |
enzymes
| @ref | value | activity | ec |
|---|---|---|---|
| 68379 | gelatinase | - | |
| 68379 | urease | + | 3.5.1.5 |
| 68379 | beta-glucosidase | + | 3.2.1.21 |
| 68379 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 |
| 68379 | alpha-glucosidase | + | 3.2.1.20 |
| 68379 | beta-galactosidase | - | 3.2.1.23 |
| 68379 | beta-glucuronidase | - | 3.2.1.31 |
| 68379 | alkaline phosphatase | - | 3.1.3.1 |
| 68379 | pyrrolidonyl arylamidase | + | 3.4.19.3 |
| 68379 | pyrazinamidase | - | 3.5.1.B15 |
| 68382 | alkaline phosphatase | - | 3.1.3.1 |
| 68382 | esterase (C 4) | + | |
| 68382 | esterase lipase (C 8) | + | |
| 68382 | lipase (C 14) | - | |
| 68382 | leucine arylamidase | + | 3.4.11.1 |
| 68382 | valine arylamidase | - | |
| 68382 | cystine arylamidase | - | 3.4.11.3 |
| 68382 | trypsin | - | 3.4.21.4 |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 |
| 68382 | acid phosphatase | + | 3.1.3.2 |
| 68382 | naphthol-AS-BI-phosphohydrolase | - | |
| 68382 | alpha-galactosidase | - | 3.2.1.22 |
| 68382 | beta-galactosidase | + | 3.2.1.23 |
| 68382 | beta-glucuronidase | - | 3.2.1.31 |
| 68382 | alpha-glucosidase | + | 3.2.1.20 |
| 68382 | beta-glucosidase | + | 3.2.1.21 |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 |
| 68382 | alpha-mannosidase | + | 3.2.1.24 |
| 68382 | alpha-fucosidase | - | 3.2.1.51 |
API coryne
| @ref | NIT | PYZ | PYRA | PAL | beta GUR | beta GAL | alpha GLU | beta NAG | ESC | URE | GEL | GLU | RIB | XYL | MAN | MAL | LAC | SAC | GLYG |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19848 | - | - | + | - | - | - | + | - | + | + | - | - | - | - | - | - | - | - | - |
API zym
| @ref | Alkaline phosphatase | Esterase | Esterase Lipase | Lipase | Leucine arylamidase | Valine arylamidase | Cystine arylamidase | Trypsin | alpha- Chymotrypsin | Acid phosphatase | Naphthol-AS-BI-phosphohydrolase | alpha- Galactosidase | beta- Galactosidase | beta- Glucuronidase | alpha- Glucosidase | beta- Glucosidase | N-acetyl-beta- glucosaminidase | alpha- Mannosidase | alpha- Fucosidase |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19848 | - | + | + | - | + | - | - | - | - | + | - | - | + | - | + | + | - | + | - |
Isolation, sampling and environmental information
taxonmaps
- @ref: 69479
- File name: preview.99_54.png
- url: https://microbeatlas.org/index.html?action=taxon&taxon_id=90_10;96_44;97_46;98_50;99_54&stattab=map
- Last taxonomy: Mycobacteroides
- 16S sequence: AF480592
- Sequence Identity:
- Total samples: 21994
- soil counts: 7046
- aquatic counts: 6199
- animal counts: 7007
- plant counts: 1742
Safety information
risk assessment
| @ref | pathogenicity human | pathogenicity animal | biosafety level | biosafety level comment |
|---|---|---|---|---|
| 11592 | yes | yes | 2 | Risk group (German classification) |
| 19848 | 2 | Risk group (German classification) | ||
| 115980 | 2 | Risk group (French classification) |
Sequence information
16S sequences
| @ref | description | accession | length | database | NCBI tax ID |
|---|---|---|---|---|---|
| 20218 | Mycobacterium abscessus DNA, 16S-23S ribosomal RNA intergenic spacer, partial sequence, strain: JCM 13569 | AB548596 | 297 | ena | 36809 |
| 20218 | Mycobacterium abscessus gene for 16S ribosomal RNA, partial sequence, strain: JCM 13569 | AB548599 | 1468 | ena | 36809 |
| 20218 | Mycobacterium abscessus 16S ribosomal RNA gene, partial sequence | AF480592 | 1441 | ena | 561007 |
| 20218 | Mycobacterium abscessus strain CIP 104536 16S ribosomal RNA gene, partial sequence | AF547892 | 540 | ena | 36809 |
| 20218 | Mycobacterium abscessus 16S rRNA gene | AJ536038 | 1455 | ena | 36809 |
| 20218 | Mycobacterium abscessus strain CIP 104536 16S ribosomal RNA gene, partial sequence | AY457071 | 1481 | ena | 36809 |
| 20218 | Mycobacterium abscessus 16S ribosomal RNA gene and 16S-23S intergenic spacer, partial sequence | AY498740 | 253 | ena | 561007 |
| 20218 | Mycobacterium abscessus 16S-23S ribosomal RNA intergenic spacer, partial sequence | AY593976 | 257 | ena | 36809 |
| 20218 | M.chelonei 16S ribosomal RNA | M29559 | 1355 | ena | 1774 |
| 20218 | M.abscessus 16S rRNA gene | X82235 | 1071 | ena | 561007 |
| 20218 | Mycobacterium abscessus murA and 16S rRNA gene | Y13910 | 1025 | ena | 561007 |
Genome sequences
| @ref | description | accession | assembly level | database | NCBI tax ID |
|---|---|---|---|---|---|
| 66792 | Mycobacteroides abscessus ATCC 19977 | GCA_000069185 | complete | ncbi | 561007 |
| 66792 | Mycobacteroides abscessus ATCC 19977 | GCA_001942505 | contig | ncbi | 561007 |
| 66792 | Mycobacterium abscessus ATCC 19977 | 561007.40 | plasmid | patric | 561007 |
| 66792 | Mycobacterium abscessus strain ATCC 19977 | 36809.5 | complete | patric | 36809 |
| 66792 | Mycobacterium abscessus subsp. abscessus strain ATCC 19977 | 1185650.503 | wgs | patric | 1185650 |
| 66792 | Mycobacteroides abscessus strain NCTC13031 | 36809.556 | wgs | patric | 36809 |
| 66792 | Mycobacteroides abscessus subsp. abscessus strain 11351-15 | 1185650.1003 | wgs | patric | 1185650 |
| 66792 | Mycobacteroides abscessus subsp. abscessus strain 12389-15 | 1185650.999 | wgs | patric | 1185650 |
| 66792 | Mycobacteroides abscessus subsp. abscessus strain 2572-15 | 1185650.997 | wgs | patric | 1185650 |
| 66792 | Mycobacteroides abscessus subsp. abscessus strain 2677-16 | 1185650.998 | wgs | patric | 1185650 |
| 66792 | Mycobacteroides abscessus subsp. abscessus strain 3563-15 | 1185650.1000 | wgs | patric | 1185650 |
| 66792 | Mycobacteroides abscessus subsp. abscessus strain 4549-15 | 1185650.1002 | wgs | patric | 1185650 |
| 66792 | Mycobacteroides abscessus subsp. abscessus strain 8844-15 | 1185650.1001 | wgs | patric | 1185650 |
| 66792 | Mycobacteroides abscessus subsp. bolletii strain 11702-16 | 319705.144 | wgs | patric | 319705 |
| 66792 | Mycobacteroides abscessus subsp. bolletii strain 13116-16 | 319705.141 | wgs | patric | 319705 |
| 66792 | Mycobacteroides abscessus subsp. bolletii strain 713-16 | 319705.142 | wgs | patric | 319705 |
| 66792 | Mycobacteroides abscessus subsp. bolletii strain 7742-15 | 319705.143 | wgs | patric | 319705 |
| 66792 | Mycobacteroides abscessus subsp. massiliense strain 10003-15 | 1962118.376 | wgs | patric | 1962118 |
| 66792 | Mycobacteroides abscessus subsp. massiliense strain 10896-16 | 1962118.378 | wgs | patric | 1962118 |
| 66792 | Mycobacteroides abscessus subsp. massiliense strain 14479-15 | 1962118.377 | wgs | patric | 1962118 |
| 66792 | Mycobacteroides abscessus subsp. massiliense strain 16155-15 | 1962118.375 | wgs | patric | 1962118 |
| 66792 | Mycobacteroides abscessus abscessus ATCC 19977 | 641522641 | complete | img | 1185650 |
| 66792 | Mycobacteroides abscessus NCTC 13031 | 2916644324 | draft | img | 36809 |
| 66792 | Mycobacteroides abscessus abscessus ATCC 19977 | 2916649437 | draft | img | 1185650 |
| 67770 | Mycobacteroides abscessus NCTC13031 | GCA_900453225 | contig | ncbi | 36809 |
GC content
| @ref | GC-content | method |
|---|---|---|
| 24966 | 64 | |
| 11592 | 64.13 | sequence analysis |
Genome-based predictions
predictions
| trait | prediction | confidence | training_data |
|---|---|---|---|
| spore-forming | no | 100 | no |
| motile | no | 95.518 | no |
| flagellated | no | 98.435 | no |
| gram-positive | yes | 91.896 | no |
| anaerobic | no | 99.558 | no |
| aerobic | yes | 91.521 | no |
| halophile | no | 93.899 | no |
| spore-forming | no | 81.181 | no |
| thermophile | no | 99.333 | no |
| glucose-util | yes | 81.147 | no |
| glucose-ferment | no | 93.327 | yes |
External links
@ref: 11592
culture collection no.: DSM 44196, ATCC 19977, CCUG 20993, CIP 104536, JCM 13569, NCTC 13031, TMC 1543, Hauduroy L948, CCUG 27982, DSM 43491
straininfo link
- @ref: 77815
- straininfo: 92877
literature
| topic | Pubmed-ID | title | authors | journal | DOI | year | mesh | topic2 |
|---|---|---|---|---|---|---|---|---|
| Phylogeny | 1581184 | Proposal of Mycobacterium peregrinum sp. nov., nom. rev., and elevation of Mycobacterium chelonae subsp. abscessus (Kubica et al.) to species status: Mycobacterium abscessus comb. nov. | Kusunoki S, Ezaki T | Int J Syst Bacteriol | 10.1099/00207713-42-2-240 | 1992 | Colorimetry, DNA, Bacterial, Mycobacterium/*classification/genetics, Mycobacterium chelonae/*classification/genetics, Nucleic Acid Hybridization, Phenotype | Phenotype |
| Enzymology | 11039248 | DNA polymorphism of Mycobacterium abscessus analyzed by infrequent-restriction-site polymerase chain reaction. | Su LH, Chia JH, Leu HS, Cheng SW, Kuo AJ, Sun CF, Wu TL | Chang Gung Med J | 2000 | Electrophoresis, Gel, Pulsed-Field, Mycobacterium chelonae/*genetics, *Polymerase Chain Reaction, *Polymorphism, Genetic, Polymorphism, Restriction Fragment Length, Reproducibility of Results | ||
| Pathogenicity | 12368432 | A polymorphic region in Mycobacterium abscessus contains a novel insertion sequence element. | Howard ST, Byrd TF, Lyons CR | Microbiology (Reading) | 10.1099/00221287-148-10-2987 | 2002 | Base Sequence, DNA Transposable Elements/*genetics, Gene Deletion, Gene Transfer, Horizontal, Genetic Variation, Humans, Molecular Sequence Data, Mycobacterium/*genetics/growth & development, Open Reading Frames/genetics, *Polymorphism, Genetic, Sequence Analysis, DNA | Genetics |
| Pathogenicity | 14521758 | [Investigation of drug-resistance to rifampin and rpoB gene sequence analysis of Mycobacterium abscessus]. | Sha W, Weng XH, Xiao HP, He GJ | Zhonghua Jie He He Hu Xi Za Zhi | 2003 | Antibiotics, Antitubercular/*pharmacology, DNA-Directed RNA Polymerases/*genetics, Drug Resistance, Bacterial, Mycobacterium chelonae/*drug effects/genetics, Rifampin/*pharmacology | Transcriptome | |
| Enzymology | 15583285 | Pulsed-field gel electrophoresis study of Mycobacterium abscessus isolates previously affected by DNA degradation. | Zhang Y, Yakrus MA, Graviss EA, Williams-Bouyer N, Turenne C, Kabani A, Wallace RJ Jr | J Clin Microbiol | 10.1128/JCM.42.12.5582-5587.2004 | 2004 | Bacterial Proteins/genetics, Buffers, Chaperonin 60, Chaperonins/genetics, DNA, Bacterial/analysis/*metabolism, Electrophoresis, Gel, Pulsed-Field/*methods, Humans, Mycobacterium/*classification/genetics, RNA, Ribosomal, 16S/genetics, Sequence Analysis, DNA, Thiourea/*pharmacology | Metabolism |
| Enzymology | 15722145 | Multicenter evaluation of mycobacteria identification by PCR restriction enzyme analysis in laboratories from Latin America and the Caribbean. | Leao SC, Bernardelli A, Cataldi A, Zumarraga M, Robledo J, Realpe T, Mejia GI, da Silva Telles MA, Chimara E, Velazco M, Fernandez J, Rodrigues PA, Guerrero MI, Leon CI, Porras TB, Rastogi N, Goh KS, Suffys P, da Silva Rocha A, dos Santos Netto D, Ritacco V, Lopez B, Barrera L, Palomino JC, Martin A, Portaels F | J Microbiol Methods | 10.1016/j.mimet.2004.11.015 | 2004 | Bacterial Proteins/chemistry/genetics, Chaperonin 60, Chaperonins/chemistry/genetics, DNA, Bacterial/chemistry/genetics, Guadeloupe, Humans, Mycobacterium/genetics/*isolation & purification, Mycobacterium Infections/*diagnosis, Polymerase Chain Reaction/*methods/standards, Restriction Mapping, South America | Pathogenicity |
| 17145951 | Hypervirulence of a rough variant of the Mycobacterium abscessus type strain. | Catherinot E, Clarissou J, Etienne G, Ripoll F, Emile JF, Daffe M, Perronne C, Soudais C, Gaillard JL, Rottman M | Infect Immun | 10.1128/IAI.00835-06 | 2006 | Animals, Disease Models, Animal, Glycolipids/biosynthesis, Glycopeptides/biosynthesis, Macrophages/immunology, Mice, Mice, Inbred C57BL, Mutation, Mycobacterium Infections, Nontuberculous/immunology/*microbiology, Mycobacterium chelonae/immunology/*pathogenicity/physiology, Survival Analysis, Tumor Necrosis Factor-alpha/biosynthesis, Virulence | ||
| Genetics | 17490474 | Genomics of glycopeptidolipid biosynthesis in Mycobacterium abscessus and M. chelonae. | Ripoll F, Deshayes C, Pasek S, Laval F, Beretti JL, Biet F, Risler JL, Daffe M, Etienne G, Gaillard JL, Reyrat JM | BMC Genomics | 10.1186/1471-2164-8-114 | 2007 | Acetyltransferases/genetics, Base Sequence, Biosynthetic Pathways/*genetics, Chromatography, Thin Layer, Evolution, Molecular, Genome, Bacterial/*genetics, Glycolipids/biosynthesis/*genetics, Glycopeptides/biosynthesis/*genetics, Molecular Sequence Data, Mycobacterium chelonae/*genetics, Sequence Analysis, DNA, Species Specificity, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Transcriptome |
| Metabolism | 19543527 | Non mycobacterial virulence genes in the genome of the emerging pathogen Mycobacterium abscessus. | Ripoll F, Pasek S, Schenowitz C, Dossat C, Barbe V, Rottman M, Macheras E, Heym B, Herrmann JL, Daffe M, Brosch R, Risler JL, Gaillard JL | PLoS One | 10.1371/journal.pone.0005660 | 2009 | Anti-Bacterial Agents/pharmacology, Chromosomes, Bacterial/ultrastructure, Cystic Fibrosis/microbiology, DNA/metabolism, Drug Resistance, Bacterial/genetics, Genetic Techniques, *Genome, Bacterial, Humans, Models, Genetic, Mycobacterium/*genetics/*pathogenicity, Mycobacterium smegmatis/genetics, Phenylacetates/metabolism, Phylogeny, Virulence/genetics, Virulence Factors/genetics | Genetics |
| Metabolism | 19851737 | Comparative analysis of immune responses to Mycobacterium abscessus infection and its antigens in two murine models. | Jeon BY, Kwak J, Lee SS, Cho S, Won CJ, Kim JM, Shin SJ | J Microbiol | 10.1007/s12275-009-0139-1 | 2009 | Animals, Antibodies, Bacterial/blood, Antigens, Antigens, Bacterial/*immunology, Colony Count, Microbial, Female, Interferon-gamma/metabolism, Leukocytes, Mononuclear/immunology, Lung/immunology/microbiology/pathology, Mice, Mice, Inbred C57BL, Mycobacterium/*immunology, Mycobacterium Infections/*immunology/microbiology | |
| Enzymology | 21084521 | Diversity of pulsed-field gel electrophoresis patterns of Mycobacterium abscessus type 2 clinical isolates. | Matsumoto CK, Chimara E, Bombarda S, Duarte RS, Leao SC | J Clin Microbiol | 10.1128/JCM.01665-10 | 2010 | Adult, Aged, Bacterial Proteins/genetics, Brazil, Bronchoalveolar Lavage Fluid/microbiology, Chaperonin 60/genetics, Cluster Analysis, DNA-Directed RNA Polymerases/genetics, Electrophoresis, Gel, Pulsed-Field, Female, *Genetic Variation, Genotype, Humans, Male, Middle Aged, Molecular Sequence Data, *Molecular Typing, Mycobacterium/*classification/*genetics/isolation & purification, Mycobacterium Infections/*microbiology, Sequence Analysis, DNA, Sputum/microbiology, Urine/microbiology | Genetics |
| Transcriptome | 21106786 | Multilocus sequence analysis and rpoB sequencing of Mycobacterium abscessus (sensu lato) strains. | Macheras E, Roux AL, Bastian S, Leao SC, Palaci M, Sivadon-Tardy V, Gutierrez C, Richter E, Rusch-Gerdes S, Pfyffer G, Bodmer T, Cambau E, Gaillard JL, Heym B | J Clin Microbiol | 10.1128/JCM.01274-10 | 2010 | Bacterial Proteins/genetics, *Bacterial Typing Techniques, Brazil, Cluster Analysis, DNA, Bacterial/chemistry/genetics, DNA-Directed RNA Polymerases/*genetics, France, Germany, Humans, Molecular Sequence Data, *Multilocus Sequence Typing, Mycobacterium/*classification/*genetics, Phylogeny, Sequence Analysis, DNA, Switzerland | Phylogeny |
| Cultivation | 22197720 | Comparative study with two different enrichments in the culture media used in the disinfectant efficacy assay. | Sabagh BP, Souto Ada S, Reis LM, Silva SA, Pereira DC, Neves Mde C, Pinheiro RR, Duarte RS, Miyazaki NH, Boas MH | J Microbiol Methods | 10.1016/j.mimet.2011.12.004 | 2011 | Animals, Brazil, Cattle, Culture Media/*chemistry, Disinfectants/*pharmacology, Glucose/pharmacology, Glutaral/pharmacology, Microbial Sensitivity Tests/*methods, Mycobacterium/*drug effects/growth & development, Statistics, Nonparametric | Pathogenicity |
| Genetics | 23294800 | Mycobacterium abscessus multispacer sequence typing. | Sassi M, Ben Kahla I, Drancourt M | BMC Microbiol | 10.1186/1471-2180-13-3 | 2013 | DNA, Bacterial/chemistry/genetics, DNA, Intergenic/chemistry/genetics, Genotype, Humans, Molecular Sequence Data, Multilocus Sequence Typing/*methods, Mycobacterium/*classification/genetics/*isolation & purification, Mycobacterium Infections/microbiology | Pathogenicity |
| Pathogenicity | 23804391 | New rapid scheme for distinguishing the subspecies of the Mycobacterium abscessus group and identifying Mycobacterium massiliense isolates with inducible clarithromycin resistance. | Shallom SJ, Gardina PJ, Myers TG, Sebastian Y, Conville P, Calhoun LB, Tettelin H, Olivier KN, Uzel G, Sampaio EP, Holland SM, Zelazny AM | J Clin Microbiol | 10.1128/JCM.01132-13 | 2013 | Anti-Bacterial Agents/*pharmacology, Bacteriological Techniques/*methods, Clarithromycin/*pharmacology, Comparative Genomic Hybridization, DNA Primers/genetics, DNA, Bacterial/chemistry/genetics, *Drug Resistance, Bacterial, Gene Expression Regulation, Bacterial/drug effects, Genetic Variation, Humans, Molecular Sequence Data, Nontuberculous Mycobacteria/*classification/drug effects/genetics, Polymerase Chain Reaction/*methods, Sequence Analysis, DNA | Genetics |
| Metabolism | 24014661 | Insertion site and distribution of a genomic island conferring DNA phosphorothioation in the Mycobacterium abscessus complex. | Howard ST, Newman KL, McNulty S, Brown-Elliott BA, Vasireddy R, Bridge L, Wallace RJ | Microbiology (Reading) | 10.1099/mic.0.070318-0 | 2013 | *Chromosomes, Bacterial, DNA, Bacterial/chemistry/genetics/*metabolism, Electrophoresis, Gel, Pulsed-Field, Gene Order, *Genomic Islands, Molecular Sequence Data, Mycobacterium/*genetics/*metabolism, Polymerase Chain Reaction, Recombination, Genetic, Sequence Analysis, DNA, Thionucleotides/*metabolism | Enzymology |
| Enzymology | 24132992 | Characterization of broad-spectrum Mycobacterium abscessus class A beta-lactamase. | Soroka D, Dubee V, Soulier-Escrihuela O, Cuinet G, Hugonnet JE, Gutmann L, Mainardi JL, Arthur M | J Antimicrob Chemother | 10.1093/jac/dkt410 | 2013 | Hydrolysis, Kinetics, Mycobacterium/*enzymology, Substrate Specificity, *beta-Lactam Resistance, beta-Lactamases/*metabolism | Metabolism |
| Pathogenicity | 24283764 | Bacterial adherence to different meshes used in abdominal surgery. | Perez-Tanoira R, Isea-Pena MC, Celdran A, Garcia-Vasquez C, Esteban J | Surg Infect (Larchmt) | 10.1089/sur.2013.032 | 2013 | Abdominal Cavity/surgery, Bacteria/*isolation & purification, *Bacterial Adhesion, Bacterial Load, Digestive System Surgical Procedures/instrumentation, Humans, Polypropylenes, Surgical Mesh/*microbiology | Enzymology |
| Phylogeny | 24330254 | A phylogenomic approach to bacterial subspecies classification: proof of concept in Mycobacterium abscessus. | Tan JL, Khang TF, Ngeow YF, Choo SW | BMC Genomics | 10.1186/1471-2164-14-879 | 2013 | Bacterial Typing Techniques, Base Sequence, DNA, Bacterial/genetics, Data Mining, Genes, Bacterial, Genomics/*methods, Minisatellite Repeats, Molecular Sequence Data, Multilocus Sequence Typing, Mycobacterium/*classification/genetics, *Phylogeny, Polymorphism, Single Nucleotide, Sequence Analysis, DNA | Genetics |
| Genetics | 25056330 | Genome sequencing of Mycobacterium abscessus isolates from patients in the united states and comparisons to globally diverse clinical strains. | Davidson RM, Hasan NA, Reynolds PR, Totten S, Garcia B, Levin A, Ramamoorthy P, Heifets L, Daley CL, Strong M | J Clin Microbiol | 10.1128/JCM.01144-14 | 2014 | Adult, Aged, Cluster Analysis, Evolution, Molecular, Female, *Genetic Variation, *Genome, Bacterial, Genotype, Humans, Male, Middle Aged, Mycobacterium/*classification/*genetics/isolation & purification, Mycobacterium Infections, Nontuberculous/*microbiology, Phylogeny, Polymorphism, Single Nucleotide, *Sequence Analysis, DNA, United States | Phylogeny |
| Metabolism | 25604746 | Aminoglycoside-modifying enzymes determine the innate susceptibility to aminoglycoside antibiotics in rapidly growing mycobacteria. | Maurer FP, Bruderer VL, Castelberg C, Ritter C, Scherbakov D, Bloemberg GV, Bottger EC | J Antimicrob Chemother | 10.1093/jac/dku550 | 2015 | Acetyltransferases/*metabolism, Aminoglycosides/*metabolism, Anti-Bacterial Agents/*metabolism, Biotransformation, Humans, Microbial Sensitivity Tests, Mycobacterium Infections, Nontuberculous/*microbiology, Nontuberculous Mycobacteria/*drug effects/enzymology/isolation & purification/*metabolism | Enzymology |
| Genetics | 25653399 | Utility of sequencing the erm(41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs. | Brown-Elliott BA, Vasireddy S, Vasireddy R, Iakhiaeva E, Howard ST, Nash K, Parodi N, Strong A, Gee M, Smith T, Wallace RJ Jr | J Clin Microbiol | 10.1128/JCM.02950-14 | 2015 | Anti-Bacterial Agents/*pharmacology, Clarithromycin/*pharmacology, *Drug Resistance, Bacterial, Genotype, Humans, Macrolides/pharmacology, Methyltransferases/*genetics, Microbial Sensitivity Tests, Molecular Sequence Data, Mutant Proteins/genetics, Mycobacterium/*drug effects/*enzymology/genetics, Sequence Analysis, DNA, United States | Pathogenicity |
| Pathogenicity | 26033732 | Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus. | Abdalla MY, Switzer BL, Goss CH, Aitken ML, Singh PK, Britigan BE | Antimicrob Agents Chemother | 10.1128/AAC.00331-15 | 2015 | Anti-Bacterial Agents/*pharmacology, Cell Line, Cystic Fibrosis/drug therapy/microbiology, Gallium/*pharmacology, Humans, Microbial Sensitivity Tests/methods, Mycobacterium Infections, Nontuberculous/drug therapy, Nontuberculous Mycobacteria/*drug effects | |
| Pathogenicity | 26929268 | Bactericidal and intracellular activity of beta-lactams against Mycobacterium abscessus. | Lefebvre AL, Dubee V, Cortes M, Dorchene D, Arthur M, Mainardi JL | J Antimicrob Chemother | 10.1093/jac/dkw022 | 2016 | Anti-Bacterial Agents/*pharmacology, Azabicyclo Compounds/pharmacology, Cells, Cultured, Drug Interactions, Humans, Macrophages/microbiology, Microbial Viability/*drug effects, Nontuberculous Mycobacteria/*drug effects/physiology, beta-Lactamase Inhibitors/pharmacology, beta-Lactams/*pharmacology | |
| Pathogenicity | 27567903 | Identification of antimicrobial activity among new sulfonamide metal complexes for combating rapidly growing mycobacteria. | Agertt VA, Bonez PC, Rossi GG, Flores Vda C, Siqueira Fdos S, Mizdal CR, Marques LL, de Oliveira GN, de Campos MM | Biometals | 10.1007/s10534-016-9951-3 | 2016 | Anti-Bacterial Agents/chemical synthesis/chemistry/*pharmacology, Coordination Complexes/chemical synthesis/chemistry/*pharmacology, Dose-Response Relationship, Drug, Metals, Heavy/chemistry/*pharmacology, Microbial Sensitivity Tests, Mycobacterium/*drug effects/*growth & development, Structure-Activity Relationship, Sulfonamides/chemistry/*pharmacology | |
| Enzymology | 27999011 | Intrinsic rifamycin resistance of Mycobacterium abscessus is mediated by ADP-ribosyltransferase MAB_0591. | Rominski A, Roditscheff A, Selchow P, Bottger EC, Sander P | J Antimicrob Chemother | 10.1093/jac/dkw466 | 2016 | ADP Ribose Transferases/*metabolism, Antitubercular Agents/*pharmacology, Cloning, Molecular, *Drug Resistance, Bacterial, Escherichia coli/drug effects/genetics, Gene Deletion, Microbial Sensitivity Tests, Mycobacterium/*drug effects/*enzymology/genetics, Recombinant Proteins/genetics/metabolism, Rifamycins/*pharmacology | Metabolism |
| Pathogenicity | 28396540 | Rifabutin Is Active against Mycobacterium abscessus Complex. | Aziz DB, Low JL, Wu ML, Gengenbacher M, Teo JWP, Dartois V, Dick T | Antimicrob Agents Chemother | 10.1128/AAC.00155-17 | 2017 | Antibiotics, Antitubercular/*pharmacology, Clarithromycin/pharmacology, Drug Resistance, Multiple, Bacterial, Humans, Microbial Sensitivity Tests, Mycobacterium Infections, Nontuberculous/*drug therapy/microbiology, Mycobacterium abscessus/*drug effects/isolation & purification, Respiratory Tract Infections/*drug therapy/microbiology, Rifabutin/*pharmacology | Enzymology |
| Pathogenicity | 28903728 | Increased survival and proliferation of the epidemic strain Mycobacterium abscessus subsp. massiliense CRM0019 in alveolar epithelial cells. | Ribeiro GM, Matsumoto CK, Real F, Teixeira D, Duarte RS, Mortara RA, Leao SC, de Souza Carvalho-Wodarz C | BMC Microbiol | 10.1186/s12866-017-1102-7 | 2017 | A549 Cells, Alveolar Epithelial Cells/*microbiology, Animals, *Cell Proliferation, Colony Count, Microbial, Host-Pathogen Interactions/*physiology, Humans, Immune Evasion, Lysosomes/metabolism, Macrophages/microbiology, Mice, *Microbial Viability, Mycobacterium abscessus/*pathogenicity/*physiology, Phagosomes/microbiology, RAW 264.7 Cells | Metabolism |
| 28933689 | galK-based suicide vector mediated allelic exchange in Mycobacterium abscessus. | Gregoire SA, Byam J, Pavelka MS | Microbiology (Reading) | 10.1099/mic.0.000528 | 2017 | |||
| Metabolism | 28961987 | Effect of beta-lactamase production and beta-lactam instability on MIC testing results for Mycobacterium abscessus. | Rominski A, Schulthess B, Muller DM, Keller PM, Sander P | J Antimicrob Chemother | 10.1093/jac/dkx284 | 2017 | Anti-Bacterial Agents/*metabolism/pharmacology, Cefoxitin/metabolism/pharmacology, Cephalosporins/pharmacology, Drug Stability, Humans, Imipenem/metabolism/pharmacology, Meropenem, Microbial Sensitivity Tests/*methods, Mutation/drug effects, Mycobacterium Infections, Nontuberculous/drug therapy/microbiology, Mycobacterium abscessus/*drug effects/enzymology/genetics, Thienamycins/metabolism/pharmacology, beta-Lactamases/*biosynthesis, beta-Lactams/*metabolism/pharmacology | Pathogenicity |
| 29044406 | Clinical Mycobacterium abscessus strain inhibits autophagy flux and promotes its growth in murine macrophages. | Kim SW, Subhadra B, Whang J, Back YW, Bae HS, Kim HJ, Choi CH | Pathog Dis | 10.1093/femspd/ftx107 | 2017 | Animals, *Autophagy, Female, Lipids, Macrophages/*microbiology/physiology, Mice, Mice, Inbred C57BL, Mycobacterium abscessus/*physiology, RAW 264.7 Cells | ||
| Pathogenicity | 29061748 | In Vitro Evaluation of Povidone-Iodine and Chlorhexidine against Outbreak and Nonoutbreak Strains of Mycobacterium abscessus Using Standard Quantitative Suspension and Carrier Testing. | Cheng A, Sun HY, Tsai YT, Wu UI, Chuang YC, Wang JT, Sheng WH, Hsueh PR, Chen YC, Chang SC | Antimicrob Agents Chemother | 10.1128/AAC.01364-17 | 2017 | Anti-Infective Agents, Local/pharmacology, Chlorhexidine/*pharmacology, Disease Outbreaks, Drug Evaluation, Preclinical/*methods/standards, Humans, Microbial Sensitivity Tests, Mycobacterium Infections, Nontuberculous/epidemiology/microbiology, Mycobacterium abscessus/*drug effects/isolation & purification, Povidone-Iodine/*pharmacology, Suspensions | Enzymology |
| Pathogenicity | 29122674 | Antibiofilm activity of nanoemulsions of Cymbopogon flexuosus against rapidly growing mycobacteria. | Rossi GG, Guterres KB, Bonez PC, da Silva Gundel S, Aggertt VA, Siqueira FS, Ourique AF, Wagnerd R, Klein B, Santos RCV, de Campos MMA | Microb Pathog | 10.1016/j.micpath.2017.11.002 | 2017 | Anti-Bacterial Agents/*pharmacology, Biofilms/*drug effects/growth & development, Brazil, Cymbopogon/*chemistry, Emulsions, Microbial Sensitivity Tests, Nontuberculous Mycobacteria/*drug effects, Oils, Volatile/chemistry/*pharmacology, Plant Exudates/*pharmacology, Plant Oils/chemistry/pharmacology | |
| Pathogenicity | 29205119 | Activity of Rifabutin and Hemi-synthetic Derivatives Against Mycobacterium abscessus. | Ramis IB, Figueiredo R, Ramos DF, Halicki PCB, von Groll A, Viveiros M, do Ceu Costa M, da Silva PEA | Med Chem | 10.2174/1573406414666171204102633 | 2018 | Animals, Anti-Bacterial Agents/chemistry/*pharmacology/toxicity, Cell Line, Mice, Microbial Sensitivity Tests, Molecular Structure, Mycobacterium abscessus/drug effects, Rifabutin/*analogs & derivatives/chemistry/*pharmacology/toxicity, Rifampin/pharmacology | |
| Pathogenicity | 29866869 | In Vitro and Intracellular Activity of Imipenem Combined with Rifabutin and Avibactam against Mycobacterium abscessus. | Le Run E, Arthur M, Mainardi JL | Antimicrob Agents Chemother | 10.1128/AAC.00623-18 | 2018 | Anti-Bacterial Agents/*pharmacology, Azabicyclo Compounds/*pharmacology, Imipenem/*pharmacology, Microbial Sensitivity Tests, Mycobacterium abscessus/*drug effects, Rifabutin/*pharmacology | |
| Pathogenicity | 30198508 | Antimycobacterial activity of veterinary antibiotics (Apramycin and Framycetin) against Mycobacterium abscessus: Implication for patients with cystic fibrosis. | Moore JE, Koulianos G, Hardy M, Misawa N, Millar BC | Int J Mycobacteriol | 10.4103/ijmy.ijmy_73_18 | 2018 | Amikacin/pharmacology, Anti-Bacterial Agents/*pharmacology, Cystic Fibrosis/drug therapy/*microbiology, Drug Resistance, Multiple, Bacterial, Framycetin/*pharmacology, Humans, Microbial Sensitivity Tests, Mycobacterium Infections, Nontuberculous/microbiology, Mycobacterium abscessus/*drug effects/isolation & purification, Nebramycin/*analogs & derivatives/pharmacology, Sputum/microbiology, Veterinary Drugs/*pharmacology | Enzymology |
| Genetics | 30351265 | A mutation in anti-sigma factor MAB_3542c may be responsible for tigecycline resistance in Mycobacterium abscessus. | Ng HF, Tan JL, Zin T, Yap SF, Ngeow YF | J Med Microbiol | 10.1099/jmm.0.000857 | 2018 | Anti-Bacterial Agents/*pharmacology, Bacterial Proteins/genetics/*metabolism, *Drug Resistance, Bacterial, Gene Expression Regulation, Bacterial, Genome, Bacterial, Microbial Sensitivity Tests, Mutation, Mycobacterium abscessus/*drug effects/*genetics, Tigecycline/*pharmacology | Metabolism |
| Phylogeny | 30445130 | A proteomics approach for the identification of species-specific immunogenic proteins in the Mycobacterium abscessus complex. | Steindor M, Nkwouano V, Stefanski A, Stuehler K, Ioerger TR, Bogumil D, Jacobsen M, Mackenzie CR, Kalscheuer R | Microbes Infect | 10.1016/j.micinf.2018.10.006 | 2018 | Bacterial Proteins/chemistry/genetics/*metabolism, Computer Simulation, Culture Media, Conditioned/chemistry, Epitopes, Genome, Bacterial/genetics, Humans, Mutation, Mycobacterium Infections, Nontuberculous/immunology/microbiology, Mycobacterium abscessus/*chemistry/classification/genetics/*immunology, Phylogeny, Proteogenomics, Species Specificity | Genetics |
| Pathogenicity | 30531035 | Antimycobacterial activity of nonantibiotics associated with the polypharmacy of cystic fibrosis (CF) against mycobacterium abscessus. | Kirkwood ZI, Millar BC, Downey DG, Moore JE | Int J Mycobacteriol | 10.4103/ijmy.ijmy_142_18 | 2018 | Anti-Allergic Agents/pharmacology, Anti-Bacterial Agents/*pharmacology, Anti-Inflammatory Agents, Non-Steroidal/*pharmacology, Chlorpheniramine/pharmacology, Cystic Fibrosis/complications/*microbiology, Humans, Microbial Sensitivity Tests, Mycobacterium Infections, Nontuberculous/drug therapy, Mycobacterium abscessus/*drug effects, Nontuberculous Mycobacteria/*drug effects/isolation & purification, *Polypharmacy | Enzymology |
| Pathogenicity | 30649327 | A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria. | Ruth MM, Sangen JJN, Remmers K, Pennings LJ, Svensson E, Aarnoutse RE, Zweijpfenning SMH, Hoefsloot W, Kuipers S, Magis-Escurra C, Wertheim HFL, van Ingen J | J Antimicrob Chemother | 10.1093/jac/dky526 | 2019 | Antitubercular Agents/*pharmacology, Clofazimine/*pharmacology, Diarylquinolines/*pharmacology, *Drug Synergism, Microbial Sensitivity Tests, Microbial Viability/drug effects, Mycobacterium abscessus/*drug effects, Mycobacterium avium Complex/*drug effects, Mycobacterium tuberculosis/*drug effects | |
| Pathogenicity | 30670428 | In Vitro Synergism of Rifabutin with Clarithromycin, Imipenem, and Tigecycline against the Mycobacterium abscessus Complex. | Cheng A, Tsai YT, Chang SY, Sun HY, Wu UI, Sheng WH, Chen YC, Chang SC | Antimicrob Agents Chemother | 10.1128/AAC.02234-18 | 2019 | Anti-Bacterial Agents/*pharmacology, Clarithromycin/*pharmacology, Drug Resistance, Bacterial/drug effects, Drug Synergism, Humans, Imipenem/*pharmacology, Macrolides/pharmacology, Microbial Sensitivity Tests, Mycobacterium Infections, Nontuberculous/*drug therapy/microbiology, Mycobacterium abscessus/*drug effects, Rifabutin/*pharmacology, Tigecycline/*pharmacology | |
| Pathogenicity | 30755518 | Dual beta-Lactam Combinations Highly Active against Mycobacterium abscessus Complex In Vitro. | Pandey R, Chen L, Manca C, Jenkins S, Glaser L, Vinnard C, Stone G, Lee J, Mathema B, Nuermberger EL, Bonomo RA, Kreiswirth BN | mBio | 10.1128/mBio.02895-18 | 2019 | Anti-Bacterial Agents/administration & dosage/*pharmacology, Ceftazidime/administration & dosage/pharmacology, Cephalosporins/administration & dosage/pharmacology, *Drug Synergism, Humans, Imipenem/administration & dosage/pharmacology, Microbial Sensitivity Tests, Microbial Viability/drug effects, Models, Biological, Mycobacterium Infections, Nontuberculous/drug therapy/microbiology, Mycobacterium abscessus/*drug effects, THP-1 Cells, Treatment Outcome, beta-Lactams/administration & dosage/*pharmacology | |
| Phylogeny | 30860186 | Antimicrobial properties of basidiomycota macrofungi to Mycobacterium abscessus isolated from patients with cystic fibrosis. | Millar BC, Nelson D, Moore RE, Rao JR, Moore JE | Int J Mycobacteriol | 10.4103/ijmy.ijmy_167_18 | 2019 | Agaricales/classification/genetics/isolation & purification/*metabolism, Anti-Bacterial Agents/*metabolism, Antibiosis, China, Cystic Fibrosis/*complications, Environmental Microbiology, Humans, Ireland, Microbial Sensitivity Tests, Mycobacterium Infections, Nontuberculous/*microbiology, Mycobacterium abscessus/*drug effects/isolation & purification | Pathogenicity |
| Enzymology | 31262763 | Auranofin Activity Exposes Thioredoxin Reductase as a Viable Drug Target in Mycobacterium abscessus. | Ruth MM, van Rossum M, Koeken VACM, Pennings LJ, Svensson EM, Ruesen C, Bowles EC, Wertheim HFL, Hoefsloot W, van Ingen J | Antimicrob Agents Chemother | 10.1128/AAC.00449-19 | 2019 | Anti-Bacterial Agents/pharmacokinetics/*pharmacology, Auranofin/pharmacokinetics/*pharmacology, Bacterial Proteins/antagonists & inhibitors/genetics, Drug Therapy, Combination, Humans, Kinetics, Macrophages/microbiology, Microbial Sensitivity Tests, Mycobacterium/drug effects, Mycobacterium Infections, Nontuberculous/drug therapy/microbiology, Mycobacterium abscessus/*drug effects/enzymology, Phylogeny, Thioredoxin-Disulfide Reductase/antagonists & inhibitors/genetics | Pathogenicity |
| Pathogenicity | 31271060 | The differential effect of clarithromycin and azithromycin on induction of macrolide resistance in Mycobacterium abscessus. | Schildkraut JA, Pennings LJ, Ruth MM, de Brouwer AP, Wertheim HF, Hoefsloot W, de Jong A, van Ingen J | Future Microbiol | 10.2217/fmb-2018-0310 | 2019 | Anti-Bacterial Agents/*pharmacology, Azithromycin/*pharmacology, Clarithromycin/*pharmacology, Drug Resistance, Bacterial/*drug effects, Gene Expression Profiling, Macrolides/pharmacology, Microbial Sensitivity Tests, Mycobacterium abscessus/*drug effects, RNA, Bacterial/analysis, RNA, Messenger/analysis, Transcriptional Activation/*drug effects | |
| Pathogenicity | 31481764 | Inhibition of Mycobacterium abscessus, M. chelonae, and M. fortuitum biofilms by Methylobacterium sp. | Garcia-Coca M, Rodriguez-Sevilla G, Perez-Domingo A, Aguilera-Correa JJ, Esteban J, Munoz-Egea MC | J Antibiot (Tokyo) | 10.1038/s41429-019-0232-6 | 2019 | Anti-Bacterial Agents/*isolation & purification/*pharmacology, Biofilms/*drug effects, Colony Count, Microbial, Methylobacterium/*chemistry, Microbial Sensitivity Tests, Microscopy, Confocal, Mycobacterium/*drug effects, Mycobacterium abscessus/drug effects | Enzymology |
| Phylogeny | 31682611 | Mycobacterium abscessus infection in the stomach of patients with various gastric symptoms. | Chouhan D, Barani Devi T, Chattopadhyay S, Dharmaseelan S, Nair GB, Devadas K, Radhakrishna Pillai M | PLoS Negl Trop Dis | 10.1371/journal.pntd.0007799 | 2019 | Adolescent, Adult, Aged, Bacterial Proteins/classification/genetics, Biopsy, Chaperonin 60/classification/genetics, Child, Coinfection, Epithelial Cells, Female, Gastric Mucosa/microbiology, Genes, Bacterial/genetics, Helicobacter Infections/*complications/*epidemiology, Helicobacter pylori/genetics, Humans, Male, Middle Aged, Mycobacterium Infections, Nontuberculous/*complications/*epidemiology, Mycobacterium abscessus/genetics/isolation & purification, Phylogeny, Prevalence, RNA, Ribosomal, 16S/genetics, Stomach/*microbiology/pathology, Young Adult | Pathogenicity |
| Stress | 31784213 | Tigecycline resistance may be associated with dysregulated response to stress in Mycobacterium abscessus. | Ng HF, Ngeow YF, Yap SF, Zin T, Tan JL | Int J Med Microbiol | 10.1016/j.ijmm.2019.151380 | 2019 | Anti-Bacterial Agents/*pharmacology, Bacterial Proteins/genetics, Drug Resistance, Bacterial/*genetics, Gene Expression Regulation, Bacterial, Mycobacterium abscessus/*drug effects/genetics, Ribosomal Proteins/genetics, Sigma Factor/genetics/metabolism, *Stress, Physiological, Temperature, Tigecycline/*pharmacology, Transcription, Genetic | Pathogenicity |
| 32810554 | Peripheral tetra-cationic Pt(II) porphyrins photo-inactivating rapidly growing mycobacteria: First application in mycobacteriology. | Rossi GG, Guterres KB, da Silveira CH, Moreira KS, Burgo TAL, Iglesias BA, de Campos MMA | Microb Pathog | 10.1016/j.micpath.2020.104455 | 2020 | Cations, Light, *Mycobacterium, Photosensitizing Agents/pharmacology, *Porphyrins | ||
| Genetics | 33707330 | Genome Sequence of Mycobacterium abscessus Phage phiT45-1. | Amarh ED, Gauthier CH, Dedrick RM, Garlena RA, Russell DA, Jacobs-Sera D, Zack KM, Hatfull GF | Microbiol Resour Announc | 10.1128/MRA.00155-21 | 2021 | ||
| Pathogenicity | 34034663 | Secretome characterization of clinical isolates from the Mycobacterium abscessus complex provides insight into antigenic differences. | Cornejo-Granados F, Kohl TA, Sotomayor FV, Andres S, Hernandez-Pando R, Hurtado-Ramirez JM, Utpatel C, Niemann S, Maurer FP, Ochoa-Leyva A | BMC Genomics | 10.1186/s12864-021-07670-7 | 2021 | Humans, *Mycobacterium Infections, Nontuberculous, *Mycobacterium abscessus/genetics, *Mycobacterium tuberculosis | |
| Genetics | 34126767 | Genome-Wide Essentiality Analysis of Mycobacterium abscessus by Saturated Transposon Mutagenesis and Deep Sequencing. | Rifat D, Chen L, Kreiswirth BN, Nuermberger EL | mBio | 10.1128/mBio.01049-21 | 2021 | *DNA Transposable Elements, *Genes, Essential, *Genome, Bacterial, Genomics/*methods, High-Throughput Nucleotide Sequencing/*methods, Humans, Mutagenesis, Insertional, Mycobacterium abscessus/*genetics/pathogenicity, Mycobacterium tuberculosis/genetics | Pathogenicity |
| 34481062 | Photo-damage promoted by tetra-cationic palladium(II) porphyrins in rapidly growing mycobacteria. | Rossi GG, Guterres KB, Moreira KS, Burgo TAL, de Campos MMA, Iglesias BA | Photodiagnosis Photodyn Ther | 10.1016/j.pdpdt.2021.102514 | 2021 | *Mycobacterium, Palladium, *Photochemotherapy/methods, Photosensitizing Agents/pharmacology, *Porphyrins/pharmacology | ||
| Pathogenicity | 34633851 | RNA Sequencing Elucidates Drug-Specific Mechanisms of Antibiotic Tolerance and Resistance in Mycobacterium abscessus. | Schildkraut JA, Coolen JPM, Burbaud S, Sangen JJN, Kwint MP, Floto RA, Op den Camp HJM, Te Brake LHM, Wertheim HFL, Neveling K, Hoefsloot W, van Ingen J | Antimicrob Agents Chemother | 10.1128/AAC.01509-21 | 2021 | Anti-Bacterial Agents/pharmacology/therapeutic use, Clarithromycin/pharmacology, Humans, Kinetics, Microbial Sensitivity Tests, *Mycobacterium Infections, Nontuberculous/drug therapy, *Mycobacterium abscessus/genetics, RNA, Sequence Analysis, RNA | Enzymology |
| Pathogenicity | 34780520 | Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant Mycobacterium abscessus. | Sudadech P, Roytrakul S, Kaewprasert O, Sirichoat A, Chetchotisakd P, Kanthawong S, Faksri K | PLoS One | 10.1371/journal.pone.0260003 | 2021 | Antimicrobial Peptides/*pharmacology, Clarithromycin/pharmacology, Drug Resistance, Bacterial/*drug effects, Erythrocytes/drug effects, Genome, Bacterial, Hemolysis, Humans, Microbial Sensitivity Tests, Microbial Viability, Mycobacterium Infections, Nontuberculous/*microbiology, Mycobacterium abscessus/drug effects/genetics/*growth & development/isolation & purification, Whole Genome Sequencing | Genetics |
| 34955859 | Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus. | Bich Hanh BT, Quang NT, Park Y, Heo BE, Jeon S, Park JW, Jang J | Front Pharmacol | 10.3389/fphar.2021.790767 | 2021 | |||
| Pathogenicity | 35311553 | Comparison of Isogenic Strains Shows No Evidence of Altered Nosocomial Transmission-Competency of Rough, GPL-Negative Mycobacterium abscessus Strains. | Meir M, Foreman M, Bar-Oz M, Naor N, Rozenblit A, Barkan D | Microbiol Spectr | 10.1128/spectrum.01990-21 | 2022 | Chlorhexidine, *Cross Infection, *Disinfectants, Humans, *Mycobacterium Infections, Nontuberculous/microbiology, *Mycobacterium abscessus/genetics | |
| Pathogenicity | 35356534 | Rapid and Accurate Differentiation of Mycobacteroides abscessus Complex Species by Liquid Chromatography-Ultra-High-Resolution Orbitrap Mass Spectrometry. | Bajaj AO, Slechta ES, Barker AP | Front Cell Infect Microbiol | 10.3389/fcimb.2022.809348 | 2022 | Chromatography, Liquid, Humans, Mass Spectrometry, *Mycobacterium abscessus, Phylogeny, Sequence Analysis, DNA | Phylogeny |
| Metabolism | 35659317 | Transposon mutagenesis in Mycobacterium abscessus identifies an essential penicillin-binding protein involved in septal peptidoglycan synthesis and antibiotic sensitivity. | Akusobi C, Benghomari BS, Zhu J, Wolf ID, Singhvi S, Dulberger CL, Ioerger TR, Rubin EJ | Elife | 10.7554/eLife.71947 | 2022 | Anti-Bacterial Agents/pharmacology, Bacterial Proteins/genetics, Cell Wall/metabolism, Mutagenesis, *Mycobacterium abscessus/genetics/metabolism, Penicillin-Binding Proteins/metabolism, Peptidoglycan/genetics |
Reference
| @id | authors | catalogue | doi/url | title | journal | pubmed |
|---|---|---|---|---|---|---|
| 11592 | Curators of the DSMZ | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 44196) | https://www.dsmz.de/collection/catalogue/details/culture/DSM-44196 | |||
| 19848 | Wink, J. | http://www.dsmz.de/microorganisms/wink_pdf/DSM44196.pdf | Compendium of Actinobacteria. HZI-Helmholtz-Centre for Infection Research, Braunschweig | |||
| 20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M. | 10.1099/ijsem.0.004332 | List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ | |||
| 20218 | Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P. | 10.1016/j.syapm.2013.11.002 | StrainInfo introduces electronic passports for microorganisms. | Syst Appl Microbiol. 37: 42-50 2014 | 24321274 | |
| 24966 | E. K. Tortoli, Thomas A.,Brown-Elliott, Barbara A.,Trovato, Alberto,Leão, Sylvia Cardoso,Garcia, Maria Jesus,Vasireddy, Sruthi,Turenne, Christine Y.,Griffith, David E.,Philley, Julie V.,Baldan, Rossella,Campana, Silvia,Cariani, Lisa,Colombo, Carla,Taccetti, Giovanni,Teri, Antonio,Niemann, Stefan,Wallace Jr., Richard J.,Cirillo, Daniela M. | 10.1099/ijsem.0.001376 | Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii and designation of Mycobacterium abscessus subsp. massiliense comb. nov | IJSEM 66: 4471-4479 2016 | 27499141 | |
| 37180 | Curators of the CIP | https://brclims.pasteur.fr/brcWeb/souche/detail/1/16455 | ||||
| 66792 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann | https://diaspora-project.de/progress.html#genomes | Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) | |||
| 67770 | Curators of the JCM | https://jcm.brc.riken.jp/en/ | ||||
| 68379 | Automatically annotated from API Coryne | |||||
| 68382 | Automatically annotated from API zym | |||||
| 69479 | João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich. | https://microbeatlas.org/ | MicrobeAtlas 1.0 beta | |||
| 69480 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann | https://diaspora-project.de/progress.html#genomes | Predictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) | |||
| 69481 | Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch | 10.21203/rs.3.rs-2527258/v1 | Predictions based on the model GenomeNet Sporulation v. 1 | |||
| 77815 | Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J. | 10.60712/SI-ID92877.1 | StrainInfo: A central database for resolving microbial strain identifiers | |||
| 115980 | Curators of the CIP | Collection of Institut Pasteur (CIP 104536) | https://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%20104536 |